MedTrace Logo

Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients

NCT06827769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-02-14

No results posted yet for this study

Summary

The goal of this observational cross-sectional study is to assess the relationship between serum levels of magnesium and zinc in pediatric and adult patients with chronic liver disease and the clinic-laboratory variables.

Researchers will compare serum levels of zinc and magnesium in patients with chronic liver disease and healthy controls. Assess the correlation between serum zinc and magnesium and the presence and severity of chronic liver disease and cirrhosis.

Participants will be subjected to history taking, clinical examination, laboratory investigations, and abdominal ultrasonography.

Conditions

  • Chronic Liver Disease and Cirrhosis

Interventions

DIAGNOSTIC_TEST

serum zinc and magnesium

participants will be subjected to laboratory investigations (complete blood picture, liver and kidney function tests, Prothrombin time, international normalized ratio (INR), serum zinc, and magnesium).

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Eman B Elsaadany · Pediatric medicine Department, Faculty of Medicine, Tanta University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-01-30
Completion
2025-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827769 on ClinicalTrials.gov